https://www.pharmaceutical-technology.com/analyst-comment/digital-biomarkers-timeline/ 2022-11-25T14:58:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/meissa-covid19-vaccine-development/ 2020-07-01T10:17:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eylea-bayer-regeneron/ 2023-01-23T13:36:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/eylea-bayer-regeneron-2/ 2020-07-01T08:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/european-solar-energy-development-shines-on/ 2020-09-18T11:34:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-10-4-million-us-corners-world-remdesivir-supplies/ 2020-07-01T08:37:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-mhra-re-starts-hydroxychloroquine-trial-japan-launches-first-covid-19-vaccine-trial/ 2021-11-25T09:39:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ipf-unmet-clinical-needs-2/ 2020-07-01T08:17:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/charting-the-ups-and-downs-of-the-world-health-organization/ 2020-06-29T08:11:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ipf-unmet-clinical-needs/ 2023-01-30T14:54:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/astrazeneca-covid-19-disruption/ 2020-07-01T08:45:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ibd-zeposia-treatment-2/ 2020-07-01T06:35:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ibd-zeposia-treatment/ 2020-07-01T06:30:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-wearing-masks-can-save-5-of-us-gdp-during-covid-19-pandemic/ 2020-07-01T06:16:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/masks-economy-covid/ 2020-07-01T06:03:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/will-ma-fill-the-post-covid-fdi-gap/ 2020-09-18T11:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/transthyretin-amyloidosis-attr-market/ 2020-06-30T14:33:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisks-insulin-candidate-trials/ 2023-01-24T16:42:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/viiv-funds-projects-to-research-covid-19-risk-in-and-impact-on-hiv-patients/ 2020-06-30T14:08:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-right-transfer-solutions-for-media-and-buffer-powders/ 2020-06-30T14:05:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-exceed-10-4-million-with-509000-deaths-lockdowns-reinstated-in-australian-state-of-victoria/ 2020-06-30T13:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-big-interview-peter-yapp-schillings-partner-and-former-ncsc-deputy-director-boards-need-a-ciso-who-reports-directly-to-them/ 2020-07-02T06:23:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/dr-anthony-fauci-covid-19-2/ 2020-06-30T13:31:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dr-anthony-fauci-covid-19/ 2020-06-30T13:29:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/meissa-starts-pre-clinical-studies-of-intranasal-lav-vaccine/ 2020-06-30T12:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-carmine-partnership/ 2020-06-30T12:31:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/the-gcc-emerges-as-a-food-security-force/ 2020-09-18T11:39:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-10-million-pandemic-speeding-up-says-who/ 2020-06-30T12:13:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/airbus-cto-grazia-vittadini-aviation-needs-to-tap-emerging-technologies-diverse-talent-to-get-climate-neutral/ 2020-06-30T12:03:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tiziana-life-sciences-stc-deal/ 2020-06-30T10:41:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-phesgo-breast-cancer/ 2020-06-30T10:08:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/there-is-a-permanent-shift-towards-ecommerce-ikea-cdo/ 2020-07-02T05:15:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/chronic-kidney-disease-covid-19-2/ 2022-09-09T11:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chronic-kidney-disease-covid-19/ 2022-12-03T08:45:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/digital-biomarkers-portable-devices/ 2022-11-30T15:19:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-recovery-trial-finds-lopinavir-ritonavir-brings-no-benefit-in-covid-19-gilead-sets-price-for-remdesivir-in-developed-countries/ 2020-06-30T08:03:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-spread-was-aided-by-resistance-to-evidence-of-asymptomatic-transmission/ 2020-06-30T06:58:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/asymptomatic-transmission-covid/ 2020-06-30T06:26:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/biontech-raises-250m-in-private-funding-from-temasek/ 2020-06-29T14:09:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/as-the-computer-misuse-act-turns-30-the-uks-tech-industry-says-reform-is-desperately-overdue/ 2020-06-29T13:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/big-pharma-2/ 2020-06-29T13:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/big-pharma/ 2020-06-29T13:22:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-pass-10-1-million-more-than-half-a-million-deaths-india-fears-second-surge/ 2020-06-29T12:58:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-remdesivir-price/ 2020-06-29T12:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-duvroq-japan-approval/ 2022-11-29T15:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/industry-4-0-to-the-rescue/ 2020-09-18T11:37:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/c4t-degrader-drugs 2020-06-29T09:54:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/digital-biomarkers-macroeconomic-themes/ 2020-06-29T09:11:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/facebook-advertising-boycott-why-brands-are-leaving-the-tech-giant/ 2020-06-29T08:39:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/dexamethasone-remdesivir-combination-covid-2/ 2020-06-29T08:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dexamethasone-remdesivir-combination-covid/ 2024-10-07T08:58:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-who-launches-the-covax-facility-focused-on-equitable-access-brazils-fiocruz-to-manufacture-100-million-doses-of-astrazenecas-covid-19-vaccine/ 2020-06-29T07:54:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-has-meant-fewer-orders-but-they-are-of-higher-value-says-softcat-ceo/ 2020-06-29T07:45:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/brazil-oxford-covid-19-vaccine/ 2020-06-29T07:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/no-certainties-in-global-economic-recovery-post-covid-19/ 2020-06-29T06:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/uncertain-covid-recovery/ 2020-06-29T06:11:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/remdesivir-calculate-the-cost-of-a-pandenmic-drug-html/ 2022-02-22T09:01:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/employees-favour-work-from-home-after-covid-19-lockdowns-easing-2/ 2020-06-26T15:21:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-breaking-the-bbb/ 2020-06-26T14:19:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/selling-a-sunlit-future-in-the-saudi-renewables-market/ 2020-09-18T11:40:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-ai-is-transforming-the-news-industry/ 2020-06-29T07:51:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/who-publishes-act-accelerators-investment-case-for-covid-19-medicines-and-vaccines/ 2020-06-26T13:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-pass-9-6-million-more-than-2-million-in-latin-america-sharp-increases-in-eastern-europe/ 2020-06-26T12:52:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-bioepis-aybintio-chmp/ 2020-06-26T12:03:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-japan-vaccine-supply/ 2020-06-26T10:20:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ogury-how-the-adtech-industry-could-change-post-pandemic/ 2020-06-26T10:17:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/unctad-report-paints-a-bleak-picture-for-global-fdi/ 2020-12-14T08:44:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-believed-to-have-20-million-covid-19-infections-consecutive-day-rise-of-5000-cases-in-florida-threat-to-close-uk-beaches/ 2020-06-26T08:49:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/digital-biomarkers-technology-themes/ 2022-11-18T13:44:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-ema-grants-conditional-approval-to-remdesivir-avalon-globocare-starts-studies-of-vaccine-with-intranasal-or-oral-administration/ 2020-06-26T09:08:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/harms-out-growth-in-pending-government-digital-strategy-posits-tech-as-economic-saviour/ 2020-06-26T10:09:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/dry-eye-syndrome-pharma-markets-2/ 2020-06-26T06:50:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dry-eye-syndrome-pharma-markets/ 2020-06-26T06:45:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avalon-covid19-vaccine/ 2020-06-26T06:52:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/unctad-forecasts-40-decline-in-fdi-due-to-covid-19-pandemic/ 2020-06-26T06:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/foreign-investments-decline-covid/ 2020-06-26T05:54:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/agreeing-to-do-it-in-four-weeks-mustve-been-a-moment-of-madness-inside-the-team-that-built-the-uks-furlough-scheme/ 2020-07-03T08:28:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/enginuity-cio-david-ivell-on-industry-4-0-upskilling-and-finding-talent-with-minecraft/ 2020-06-25T16:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-reach-a-daily-global-record-high-with-more-than-212000-infections/ 2020-06-25T13:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-catalent-vaccine-deal/ 2021-10-27T10:55:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cto-talk-qa-with-amdocss-angela-logothetis/ 2020-06-25T15:02:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sosei-heptares-abbvie-alliance/ 2020-06-25T10:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/novo-nordisk-corvidia-deal 2020-06-25T13:35:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/yumanity-therapeutics-merck-deal/ 2020-06-25T09:40:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-expected-to-pass-10-million-by-weekend-us-confirms-second-highest-one-day-total/ 2020-06-25T09:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/could-nanoparticles-unlock-the-benefits-of-turmeric/ 2023-06-12T04:01:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/where-now-for-british-manufacturing/ 2020-12-14T08:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-cepi-to-sign-manufacturing-deals-for-covid-19-vaccines-fulcrum-to-launch-phase-iii-study-of-losmapimod/ 2020-06-25T07:35:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/targeted-policies-essential-for-post-covid-economic-recovery-accuracy-of-covid-19-data-cannot-be-trusted-globally/ 2020-06-25T06:53:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/economies-response-covid/ 2020-06-25T06:25:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/anticoagulants-improve-covid-survival/ 2023-06-01T10:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/web-summit-ceo-hybrid-virtual-physical-events-are-the-future-for-conferences/ 2020-06-25T15:03:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-near-9-3-million-world-wide-saudi-arabia-restricts-hajj-infections-rise-in-iran/ 2020-06-24T13:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/esg-comes-to-the-fore-amid-covid-19-crisis/ 2020-09-18T11:46:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-vaccine-response-pigs-study/ 2020-09-04T07:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-near-9-3-million-while-deaths-approach-478000-disturbing-surge-in-cases-in-us/ 2020-06-24T11:02:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/north-china-investment-opportunities-2/ 2020-06-24T10:51:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/north-china-investment-opportunities/ 2021-12-02T06:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neurorx-fda-covid-fast-track/ 2020-06-24T09:49:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/self-driving-hospital-beds-and-social-distancing-sensors-covid-19-innovation/ 2020-06-25T15:03:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-oxford-university-begins-covid-19-vaccine-trials-in-brazil-chinese-covid-19-vaccines-enters-phase-iii-studies-in-the-uae/ 2020-06-24T08:09:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/what-makes-estonias-thriving-startup-ecosystem-tick/ 2020-06-25T15:04:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-pionyr-immunotherapeutics/ 2020-06-24T07:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economists-highlight-self-induced-and-covid-19-driven-recessions/ 2020-06-24T06:57:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/covid-induced-recession/ 2020-06-24T06:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cisco-cso-judge-the-tech-industrys-covid-19-role-in-18-months/ 2020-06-25T15:04:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-exceed-9-1-million-numbers-still-increasing/ 2020-06-23T14:12:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sarepta-codiak-biosciences-deal/ 2021-11-22T07:26:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/digital-biomarkers-healthcare-trends/ 2023-03-01T09:34:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-vaccines-consortium-uk/ 2020-06-23T10:29:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/motor-oil-group-cio-nick-giannakakis-interview-on-digital-transformation-covid-and-edge-computing/ 2020-06-24T12:15:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-translate-bio-vaccines-deal/ 2020-06-23T09:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/blurred-lines-the-challenges-of-taking-down-ransomware-gangs/ 2020-06-26T10:13:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/rethinking-office-space-in-a-post-covid-environment/ 2020-09-18T13:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/industry-4-0-from-the-ashes-of-the-pandemic/ 2020-06-25T11:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/british-army-and-parliament-cios-join-inaugural-cio-town-hall-live/ 2020-06-25T12:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/life-as-a-service-the-unstoppable-rise-of-the-subscription-model/ 2020-06-25T11:29:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/what-is-low-code-and-could-it-turbocharge-your-business/ 2020-06-25T11:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/nvidia-cto-steve-oberlin-im-most-excited-about-the-hybridisation-of-hpc-and-ai/ 2020-06-25T11:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-9-million-alarming-surge-to-2-3-million-in-us/ 2020-06-23T08:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gilead-to-study-inhaled-formulation-of-remdesivir-who-calls-for-increased-production-of-dexamethasone-globally/ 2020-06-23T07:37:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/three-quarters-of-global-workforce-could-lose-jobs-due-to-covid-19/ 2020-06-23T06:59:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/global-workforce-losing-jobs/ 2020-06-23T06:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-us-and-brazil-report-more-than-half-daily-covid-cases-as-global-numbers-near-9-million-south-korea-experiencing-second-wave/ 2020-06-22T13:28:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cipla-hetero-remdesivir-covid-19/ 2021-10-27T11:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/calliditas-ipo-igan-kidney-disease 2020-06-22T12:00:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uks-dsru-and-university-of-dundee-to-monitor-covid-19-vaccines-post-approval/ 2020-06-22T10:42:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-china-approval/ 2022-11-16T13:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-near-9-million-deaths-approach-half-million-quarantine-clashes-in-germany/ 2020-06-22T08:10:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-nih-and-novartis-halt-hydroxychloroquine-trials-two-companies-to-treat-patients-in-india-with-gileads-remdesivir/ 2020-06-22T07:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glenmark-favipiravir-covid-nod/ 2021-12-02T06:17:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/investors-may-be-too-optimistic-of-rapid-economic-recovery/ 2020-06-22T06:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/economic-recovery-us-premature/ 2020-06-22T06:05:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/retinitis-pigmentosa-gene-therapies-2/ 2021-10-27T09:57:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/retinitis-pigmentosa-gene-therapies/ 2023-02-16T05:14:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-peru-2/ 2020-06-19T14:10:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-peru/ 2020-06-19T14:06:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/als-global-day-cure-2/ 2020-06-19T13:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/als-global-day-cure/ 2020-06-19T13:19:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-approach-8-5-million-infections-rising-fast-in-latin-america-and-africa/ 2020-06-19T12:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/epizyme-tazverik-follicular-lymphoma/ 2020-06-22T09:40:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alpine-immune-abbvie-immunology/ 2020-06-19T10:53:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-death-toll-passes-453000-infections-top-165000-in-pakistan-and-mexico/ 2020-06-19T09:08:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-moderna-signs-access-deals-with-israel-for-covid-19-vaccine-russian-institutes-begin-clinical-trials-of-covid-19-vaccine-candidate/ 2020-06-19T08:16:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/students-face-future-earnings-loss-due-to-covid-19/ 2020-06-19T07:05:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/students-drop-out-covid/ 2020-06-19T06:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/indias-cdri-trial-umifenovir-covid-19/ 2023-01-24T16:42:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tonix-southern-research-vaccine/ 2020-06-18T13:16:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-drug-sales-boost-2/ 2020-06-18T13:07:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-drug-sales-boost/ 2023-03-01T09:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-approach-8-4-million-who-fears-devastation-for-yemen/ 2020-06-18T12:42:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/orca-bio-financing-round/ 2020-06-18T10:28:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pds-biotechnology-farmacore-covid-vaccine/ 2020-06-18T10:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/disputing-the-facts-is-the-legal-battle-between-veeva-and-iqvia-an-antitrust-issue/ 2020-06-18T09:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-death-toll-nears-450000-no-us-lockdown-as-cases-rise-vaccines-may-be-available-next-year/ 2020-06-18T08:51:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/who-suspends-recruitment-of-hydroxychloroquine-in-solidarity-trial-again/ 2020-06-18T08:15:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/dexamethasone-the-first-drug-to-improve-survival-chances-for-covid-19-patients/ 2020-06-18T08:13:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/dexamethasone-covid-19-uk/ 2020-06-17T16:08:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-roches-actemra-not-more-effective-than-standard-treatment-curevac-begins-clinical-trials-of-its-vaccine/ 2020-06-18T08:03:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-economic-recovery-could-be-stalled-by-global-dependency/ 2020-06-18T06:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/inherent-structural-forces-within-the-us-economy-hindering-recovery-according-to-leading-macroeconomic-influencers/ 2020-06-18T06:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-near-8-2-million-latin-america-the-new-epicentre-fears-of-second-wave-in-europe-as-lockdowns-ease/ 2020-06-17T14:16:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/university-of-dundee-and-evgen-team-up-on-covid-19-trial/ 2020-06-17T14:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-vaccines-strategy-covid-19/ 2020-06-17T11:45:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-neurocrine-biosciences-deal/ 2021-12-02T07:17:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/mhra-suspends-recruitment-for-all-uk-hydroxychloroquine-trials/ 2020-06-17T14:16:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-deaths-pass-440000-cheap-steroid-hailed-as-major-life-saving-breakthrough/ 2020-06-17T08:45:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-vaccines-at-risk/ 2020-06-16T15:49:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-first-covid-19-drug-aproved-for-nhs-use-astrazeneca-signs-a-supply-deal-for-its-covid-19-vaccine-with-cobra/ 2020-06-17T07:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-economic-stimulus-packages-insufficient-for-speedy-recovery-post-covid-19-economists-warn/ 2020-06-17T06:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/relief-measures-stimulus-packages/ 2020-06-17T06:38:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-approves-dexamethasone/ 2020-06-17T06:43:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/positive-covid-19-test-rates-steadily-declining-us-2/ 2020-06-16T16:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/positive-covid-19-test-rates-steadily-declining-us/ 2020-06-16T16:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/clinical-trial-continuity-in-asia-pacific-during-the-covid-19-pandemic/ 2024-03-05T17:15:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-us-and-brazil-worst-affected-by-covid-19-as-global-cases-pass-8-million-steep-increases-in-peru-and-india/ 2020-06-16T12:40:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/3d-printing-in-healthcare-timeline/ 2022-11-23T12:01:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-vaccine-site-france/ 2020-06-16T11:01:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-8-million-new-beijing-outbreak-very-grim-say-officials-india-to-re-impose-lockdown/ 2020-06-16T09:25:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/germany-investment-curevac/ 2020-06-16T09:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/novo-ventures-nodthera-inflammation 2020-06-15T11:31:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-lilly-starts-phase-iii-trial-of-baricitinib-fda-revokes-emergency-license-for-hydroxychloroquine/ 2020-06-16T08:01:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-recession-short-but-sharp-predicts-morgan-stanley/ 2020-06-16T06:28:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/global-economy-recovery/ 2020-06-16T06:17:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-revokes-hcq-authorisation/ 2020-06-16T06:25:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/german-government-invests-e300m-in-curevacs-vaccines/ 2020-06-15T14:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-confirmed-cases-of-covid-19-over-7925000-us-most-heavily-affected/ 2020-06-15T13:26:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/3d-printing-covid/ 2023-02-13T06:23:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-plans-covid-vaccine/ 2021-10-31T14:25:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-near-8-million-second-wave-hits-beijing-who-say-england-should-not-lift-lockdown/ 2020-06-15T12:03:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/covid-19-and-infrastructure-missing-the-personal-touch/ 2020-09-18T13:44:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viiv-fda-approval-tivicay-children/ 2020-06-15T10:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/minority-ethnic-groups-die-covid-19-uk-us-2/ 2020-06-15T09:08:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/minority-ethnic-groups-die-covid-19-uk-us/ 2020-06-15T09:04:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/selexipag-pulmonary-arterial-hypertension-children-2/ 2020-06-15T08:40:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/selexipag-pulmonary-arterial-hypertension-children/ 2023-05-09T07:04:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/3d-printing/ 2022-11-23T12:02:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazeneca-to-supply-400-million-doses-of-covid-19-vaccine-to-iva-gilead-signs-manufacturing-agreements-with-two-indian-companies/ 2020-06-15T07:34:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/government-policy-changes-needed-to-address-the-new-normal/ 2020-06-15T07:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/policy-changes-needed-covid/ 2020-06-15T06:22:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-vaccine-supply-eu/ 2020-09-04T12:01:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-us-covid-19-infections-pass-2-million-india-fourth-most-affected-country-as-cases-approach-300000/ 2020-06-12T15:43:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-celltrion-deal/ 2020-06-12T11:48:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-buys-corvidia-therapeutics/ 2020-06-12T10:34:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/stabilitech-signs-a-manufacturing-deal-with-biocell-for-its-oral-covid-19-vaccine/ 2020-06-12T10:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-7-5-million-brazil-infections-pass-800000-transmissions-accelerating-in-africa/ 2020-06-12T09:58:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/peptidream-merck-covid-19-therapies/ 2021-11-25T11:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazeneca-signs-a-deal-with-emergent-biosciences-to-support-vaccine-development-peptidream-and-merck-to-partner-on-developing-peptide-drugs-for-covid-19/ 2020-06-12T08:03:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/global-trade-to-decline-by-27-in-q2-says-unctad/ 2020-06-12T06:36:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/global-trade-shrink/ 2020-06-12T06:13:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-gilead-merger-2/ 2020-06-11T15:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-gilead-merger/ 2024-10-07T08:58:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-moves-towards-phase-iii-for-covid-19-vaccine/ 2020-06-11T14:57:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-approach-7-5-million-egypt-most-affected-country-in-africa/ 2020-06-11T13:12:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/regeneron-advances-antiviral-antibody-drugs-into-covid-19-clinical-trials/ 2020-06-11T12:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-genmab-deal/ 2020-06-11T12:37:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-vaccine-eib-debt-financing/ 2020-06-11T10:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/jj-expedites-phase-i-iia-trial-of-covid-19-vaccine-candidate/ 2020-06-11T10:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/singapore-approves-gileads-remdesivir-to-treat-covid-19/ 2020-06-11T10:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/covid-19-latin-america-slow-start-peak-not-reached/ 2020-06-11T09:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-latin-america-slow-start-peak-not-reached-2/ 2020-06-11T09:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/singapore-remdesivir-approval/ 2020-06-11T09:48:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-dark-side-of-anticoagulants-will-a-new-approach-shed-any-light/ 2020-06-05T11:11:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/european-investment-bank-commits-e100m-to-biontechs-covid-19-vaccine/ 2020-06-11T08:37:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-covid-19-cases-exceed-2-million-deaths-approach-113000-india-swamped-by-rising-infections/ 2020-06-11T08:34:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vitamin-d-covid-19-2/ 2020-06-11T08:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vitamin-d-covid-19/ 2024-05-10T07:00:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gsk-to-study-otilimab-in-covid-19-pneumonia-twist-and-serimmune-partner-on-coronavirus-antibody-drugs/ 2021-12-02T09:21:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/second-covid-19-wave-could-see-worst-contraction-in-global-economy-in-100-years/ 2020-06-11T06:24:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-pandemic-2/ 2020-06-11T06:15:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/covid19-treatments-no-magic-bullet-html/ 2021-11-02T03:19:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/panacea-biotec-refana-vaccine/ 2020-06-10T13:44:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/new-zealand-covid-19-2/ 2020-06-10T13:21:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-pass-7-2-million-us-brazil-and-uk-have-most-active-cases/ 2020-06-10T13:20:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/new-zealand-covid-19/ 2020-06-10T13:18:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/mmv-to-support-drug-discovery-for-covid-19-by-facilitating-access-to-80-compounds/ 2020-06-10T11:03:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-denmark-facility-investment/ 2020-06-10T10:09:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-world-faces-food-crisis-following-covid-19-pandemic-warns-un-21-us-states-report-weekly-increase-in-covid-cases/ 2020-06-10T09:25:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-daewoongs-niclosamide-removes-sars-cov2-from-lungs-in-animal-tests-gsk-trials-ra-drug-against-covid-19-pneumonia/ 2020-06-10T08:45:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/baselaunch 2020-06-11T11:23:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daewoong-niclosamide-animal-data/ 2021-12-02T09:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/central-banks-need-to-play-a-more-active-role-in-covid-19-economic-recovery/ 2020-06-10T06:19:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/investment-support-covid/ 2020-06-10T06:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/operation-warp-speed-finalists-funding-initiative/ 2020-09-07T13:53:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-licences-covid-19-antibody-candidates-from-vu/ 2020-06-09T13:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-antibody-licensing/ 2020-06-09T13:21:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-pass-7-1-million-us-brazil-and-russia-most-affected-uk-second-most-deaths-behind-us/ 2020-06-09T13:02:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-biologics-roche-deal/ 2020-06-09T10:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-nafamostat-covid-19/ 2020-06-09T10:19:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-pandemic-worsening-globally-says-who-analysis-suggests-virus-in-china-earlier-than-estimated/ 2020-06-09T08:25:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/modelling-the-human-body-a-game-changer-for-drug-testing/ 2020-06-19T14:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-ema-to-conduct-expedited-review-of-remdesivir-indias-bsvl-to-conduct-phase-iii-trial-of-sepsis-drug/ 2020-06-09T07:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecasts-may-not-be-accurate-due-to-covid-19-unpredictability/ 2020-06-09T06:36:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/economic-prediction-models-covid/ 2020-06-09T06:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fda-emergency-use-screening-software-covid-19-2/ 2020-06-08T15:02:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-emergency-use-screening-software-covid-19/ 2020-06-08T14:58:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/staidson-teams-up-with-pivotal-for-study-of-its-antibody-drug-in-severe-covid-19/ 2020-06-08T13:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-exceed-7-million-india-and-brazil-still-showing-rises-eu-remains-stable/ 2020-06-08T13:19:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-buys-engage-therapeutics/ 2020-06-08T12:23:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ferrings-milprosa-approval-female-infertility/ 2020-06-08T08:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-biomedica-vmic-deal/ 2020-06-08T11:08:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazeneca-reports-positive-data-for-calquence-in-covid-19-abbvie-to-develop-a-monoclonal-antibody-therapeutic-with-three-partners/ 2020-06-08T10:49:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-partners-antibody-covid-19/ 2020-06-08T10:46:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-infections-pass-7-million-us-exceeds-1-9-million-15-countries-have-more-than-100000-cases/ 2020-06-08T09:48:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-plasma-hyperimmune-therapies/ 2021-01-03T14:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/monetary-systems-need-to-be-global-during-covid-crisis/ 2020-06-08T07:23:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/international-monetary-system-covid/ 2020-06-08T07:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/prep-england-postponed/ 2020-06-09T09:50:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-india-risk-2/ 2020-06-05T15:11:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-india-risk/ 2020-06-05T15:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-update-covid-19-cases-continue-to-rise-mass-gatherings-a-cause-for-concern/ 2020-06-05T13:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intravacc-intranasal-vaccine/ 2020-06-05T12:28:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-cepi-uq-covid-19-vaccine/ 2021-10-31T14:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-vaccine-manufacturing/ 2020-06-05T10:25:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/lancet-retracts-hydroxychloroquine-study-associated-with-surgisphere/ 2020-06-05T08:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-6-6-million-brazil-death-toll-third-highest-world-wide-argentina-extends-lockdown/ 2020-06-05T08:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazeneca-to-provide-300-million-doses-of-vaccine-to-cepi-and-gavi-eu-to-use-2-7bn-emergency-fund-for-covid-19-vaccines/ 2020-06-05T08:01:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ecb-announces-economic-stimulus-package-for-euro-zone/ 2020-06-05T06:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/euro-zone-gdp-ecb/ 2020-06-05T06:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-exceed-6-5-million-infections-still-on-the-rise-in-india-challenges-in-containment-remain/ 2020-06-04T15:23:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/india-covid-19-coronavirus-updates-status-by-state/ 2022-03-15T06:55:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-reasons-why-covid-19-antibody-tests-are-causing-confusion/ 2020-06-04T14:09:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-antibody-tests/ 2020-09-07T14:10:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/3d-printing-healthcare-2/ 2022-11-23T12:02:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-safe-are-simple-painkillers/ 2020-06-08T12:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/intravacc-partners-with-two-dutch-universities-on-covid-19-vaccine/ 2020-06-04T13:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/asco-2020-keytruda-hodgkin-lymphoma-2/ 2020-06-04T13:17:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/asco-2020-keytruda-hodgkin-lymphoma/ 2020-06-04T13:14:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/memo-therapeutics-covid-antibodies/ 2020-06-04T12:55:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hopes-of-global-economic-recovery-worsen-in-may-covid-19/ 2020-06-04T09:50:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-accent-therapeutics/ 2020-06-04T10:51:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novavax-vaccine-agc-biologics/ 2020-06-04T10:01:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-100000-covid-cases-per-day-reported-to-who-south-korea-faces-resurgence-autopsy-reveals-george-ford-had-covid-19/ 2020-06-04T12:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/hydroxycloroquine-found-to-offer-no-protection-following-covid-19-exposure/ 2020-06-04T08:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/white-house-chooses-five-operation-warpspeed-finalists-according-to-new-york-times/ 2020-06-04T08:23:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/ai-exscientia-series-c-60m 2020-06-04T08:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-brazil-launches-clinical-trials-of-oxfords-covid-19-vaccine-who-re-starts-paused-hydroxychloroquine-trial/ 2020-06-04T08:01:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/unemployment-expected-to-reach-20-in-us/ 2020-06-04T06:23:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unemployment-surge-covid/ 2020-06-04T06:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/remote-client-audits-regulatory-inspections/ 2020-10-20T12:00:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/3d-printing-healthcare/ 2020-06-18T12:11:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/governments-to-the-rescue-how-different-countries-will-utilise-infrastructure-to-emerge-from-covid-19/ 2020-12-11T16:21:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/covid-twitter-garrett-plague/ 2020-06-10T13:12:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-still-on-the-rise-in-brazil-global-cases-number-more-than-6-4-million-us-faces-second-wave/ 2020-06-03T13:03:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-ec-approval-sarclisa/ 2020-06-03T12:13:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/asco-2020-drug-development-2/ 2020-06-03T11:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/asco-2020-drug-development/ 2020-06-03T11:41:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/baylor-college-covid-19-vaccine/ 2020-06-03T10:39:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-brazils-covid-death-toll-passes-31000-lockdown-latest-economic-impacts/ 2020-06-03T08:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-investment-infectious-disease/ 2020-06-03T09:36:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gilead-receives-more-emergency-use-authorisations-for-remdesivir-bergenbio-doses-first-participants-in-the-uks-accord-trial/ 2020-06-03T07:58:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/developing-nations-will-suffer-worst-from-economic-downturn-post-covid-19/ 2020-06-03T06:55:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/economic-downturn/ 2020-06-03T06:39:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intravacc-epivax-vaccine/ 2020-06-03T07:16:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/roller-compaction-press-force/ 2020-06-03T07:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharmas-spend-tv-ads-traffic-branded-websites/ 2020-06-02T14:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/remdesivir-mhra-approval-covid-19-2/ 2020-06-02T14:21:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/remdesivir-mhra-approval-covid-19/ 2020-06-02T14:17:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-infection-rate-slows-in-europe-asia-north-america-belgium-deaths-over-800-per-million/ 2020-06-02T14:09:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-jacobio-pharmaceuticals-deal/ 2020-06-02T12:37:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-intellia-expand-alliance/ 2020-06-02T11:26:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/clinical-trials-analysis/global-clinical-trial-activity-in-q1-2020/ 2020-06-03T06:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-biosolutions-covid-19-manufacturing/ 2021-12-02T12:08:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-deaths-exceed-375000-cases-still-rising-in-central-and-south-america-latest-lockdown-updates/ 2020-06-02T09:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/relief-therapeutics-doses-patients-in-phase-iib-iii-study-for-ards-in-covid-19/ 2020-06-02T09:15:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-new-summary-gilead-reports-phase-iii-results-for-remdesivir-emergent-wins-us-government-contract-for-vaccine-manufacturing/ 2020-06-02T08:30:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/atea-215m-covid-19 2020-06-01T13:39:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/federal-reserve-intervention-needs-to-be-cautious-when-addressing-covid-19-economic-downturn/ 2020-06-02T06:39:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/federal-reserve-covid/ 2020-06-02T06:22:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/bullous-pemphigoid-inhibitors-refractory-patients-2/ 2020-06-01T14:03:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bullous-pemphigoid-inhibitors-refractory-patients/ 2023-06-26T05:46:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-more-than-372000-covid-19-deaths-globally-cases-rise-in-brazil-and-qatar-risk-of-second-wave-in-us/ 2020-06-01T13:35:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/eli-lilly-launches-worlds-first-clinical-trial-of-antibody-based-drug-for-covid-19/ 2020-06-01T12:43:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-brilinta-fda-approval/ 2020-06-01T12:12:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-covid-19-antibody-animal-data/ 2020-06-01T10:43:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gilead-remdesivir-us-stockpiling-covid-19-2/ 2020-06-01T10:15:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gilead-remdesivir-us-stockpiling-covid-19/ 2020-06-01T10:14:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/finding-a-cure-for-hiv-with-viiv-healthcare-and-unc-chapel-hill/ 2020-06-01T10:26:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-brazil-covid-19-cases-pass-half-million-mark-more-than-1000-fatalities-in-chile-latest-lockdown-updates/ 2020-06-01T09:37:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/coronavirus-company-news-summary-moderna-starts-doses-participants-in-phase-ii-covid-19-vaccine-trial-gileads-remdesivir-receives-conditional-approval-in-taiwan/ 2020-06-01T07:52:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/collaboration-across-multiple-fields-essential-to-drive-economic-recovery-post-covid-19/ 2020-06-01T06:35:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/collaboration-covid-influencers/ 2020-06-01T06:25:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/russia-approves-avifavir/ 2020-09-04T04:54:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-americas-account-for-more-than-50-of-new-covid-19-cases-globally-numbers-continue-to-grow-in-india/ 2020-05-31T10:28:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/anti-tnf-therapy-could-treat-patients-suffering-from-covid-19-related-ards/ 2020-05-29T15:16:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ards-covid-19-anti-tnf-therapy/ 2020-05-29T15:09:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cruk-and-partners-launch-trial-repurposing-camostat-in-covid-19/ 2020-05-29T15:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-illness-children-2/ 2020-05-29T14:19:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-illness-children/ 2020-05-29T14:15:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-exports-to-china-could-fall-by-46-40-million-unemployed-in-us-international-community-needs-to-revisit-finance-goals/ 2020-05-29T14:08:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/irt-a-competitive-advantage-to-accelerate-clinical-trials/ 2020-06-04T07:55:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chimeron-bio-covid-19-vaccine/ 2020-05-29T12:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avexis-manufacturing-covid-19-vaccine/ 2020-07-16T09:36:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-pandemic-vaccine-adjuvant/ 2020-05-29T10:10:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-astrazeneca-signs-a-vaccine-manufacturing-deal-with-oxfordbiomedica-novartis-enters-covid-19-vaccine-race/ 2020-05-29T08:34:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-infections-exceed-5-8-million-more-than-100000-covid-deaths-in-us/ 2020-05-29T08:21:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-pandemic-may-increase-chinas-deficit-to-historic-high/ 2020-05-29T06:35:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-deficit-influencers/ 2020-05-29T06:29:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-south-america-the-new-covid-epicenter-in-north-america-mexico-reports-its-highest-daily-total/ 2020-05-28T21:47:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/mind-the-gap-stimulus-packages-set-to-give-developed-countries-post-covid-19-advantage/ 2020-09-07T15:46:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gsk-to-produce-1bn-covid-19-vaccine-adjuvant-doses-by-2021/ 2020-05-28T14:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-more-women-losing-jobs-than-men-ecb-says-financial-stability-is-at-risk-estimated-56-million-out-of-work-in-china/ 2020-05-28T13:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-arcus-biosciences-deal/ 2021-11-22T07:37:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novavax-buys-praha-vaccines/ 2020-05-28T10:32:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/advent-delivers-4000-doses-of-oxfords-covid-19-vaccine-to-support-trial/ 2020-05-28T10:06:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/atriva-therapeutics-starts-phase-ii-study-of-small-molecule-drug-against-covid-19/ 2020-05-28T09:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ccr4-antagonists-immuno-oncology-therapies-2/ 2020-05-28T09:16:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ccr4-antagonists-immuno-oncology-therapies/ 2022-12-28T11:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-near-5-7-million-more-than-100000-deaths-in-us-as-states-relax-lockdowns/ 2020-05-28T08:39:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-uk-follows-in-frances-footsteps-and-halts-hydroxychloroquine-trial-roche-initiates-trial-combining-its-actemra-with-gileads-remdesivir/ 2020-05-28T08:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/no-time-to-waste-repurposing-drugs-to-tackle-covid-19/ 2020-05-27T14:47:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iibr-covid-19-drugs-study/ 2022-12-03T09:45:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-pandemic-could-cause-housing-crisis-in-us/ 2020-05-28T06:44:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-housing-crisis/ 2020-05-28T06:35:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-exceed-5-6-milllion-infections-rising-in-brazil-russia-india-and-south-africa/ 2020-05-28T05:45:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-importance-of-early-testing-a-comparison-of-the-us-and-south-korea/ 2020-05-27T15:17:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/importance-early-testing/ 2020-05-27T15:16:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-fitch-ratings-cuts-gdp-forecasts-again-mckinsey-see-opportunities-for-a-greener-recovery/ 2020-05-27T14:23:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/france-bans-the-prescription-of-hydroxychloroquine-for-covid-19-patients/ 2020-05-27T14:23:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-series-b-funding/ 2020-05-27T12:48:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-cases-india-2/ 2020-05-27T12:46:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-cases-india/ 2020-05-27T12:40:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/hot-on-the-heels-of-canadian-government-funding-abcellera-closes-series-b-round-at-195m/ 2020-05-27T11:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chloroquine-bayer-donation-covid-19/ 2021-06-01T10:31:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/chloroquine-bayer-donation-covid-19-2/ 2020-05-27T09:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-pandemic-pricing/ 2020-05-27T10:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-remdesivir-covid-19/ 2020-05-27T10:20:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-generics-industry-and-covid-19/ 2020-05-27T10:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/generics-covid-19-accord-qa/ 2020-05-28T11:12:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/opioid-use-disorder-covid-19-2/ 2020-05-27T08:48:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/opioid-use-disorder-covid-19/ 2020-05-27T08:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-merck-joins-race-to-find-covid-19-vaccines-and-antiviral-drugs-glenmark-launches-trial-combining-favipiravir-with-umifenovir/ 2020-05-27T07:53:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sluggish-economic-recovery-predicted/ 2020-05-27T06:23:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-covid-19-vaccines-drug/ 2020-05-27T06:54:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-pandemic/ 2020-05-27T06:12:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-us-covid-19-deaths-approach-100000-cases-still-on-the-increase-in-brazil-japan-lifts-state-of-emergency/ 2020-05-27T05:48:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-likely-to-increase-incidence-of-hospital-delirium/ 2020-05-26T15:31:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-likely-increase-hospital-delirium/ 2020-05-26T15:29:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-concerns-increase-in-may-2020/ 2020-05-28T11:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sanofi-regeneron-business-venture-2/ 2020-05-26T13:58:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sanofi-regeneron-business-venture/ 2021-11-23T08:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/supported-by-barda-merck-collaborates-with-iavi-on-covid-19-vaccine/ 2020-05-26T13:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-sanofi-shares-repurchase/ 2020-05-26T12:29:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-big-interview-cisco-uk-and-ireland-ceo-david-meads/ 2020-09-18T13:48:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canada-usask-covid-19-vaccine/ 2020-05-26T11:05:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sunovion-pharmaceuticals-kynmobi-parkinsons-2/ 2020-05-26T09:16:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sunovion-pharmaceuticals-kynmobi-parkinsons/ 2023-07-19T05:29:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uks-mhra-grants-early-access-to-remdesivir-to-severe-covid-19-patients/ 2020-05-26T16:24:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/veeva-rd-summit-patients/ 2023-01-24T16:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaxine-medytox-covid-19-vaccine/ 2021-12-01T13:09:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/synthetic-peptides-covid-19-candidates-2/ 2020-05-26T08:49:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/synthetic-peptides-covid-19-candidates/ 2022-11-25T16:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-who-warns-of-second-covid-19-peak-as-lockdowns-ease-indonesia-deploys-army-and-police-after-record-infections-surge/ 2020-05-26T08:42:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cansino-biologics-publishes-phase-i-results-of-its-covid-19-vaccine/ 2020-05-26T08:21:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-who-halts-hydroxychloroquine-trial-over-safety-concerns-novavax-and-russian-vector-to-separately-launch-vaccine-trials-in-roughly-month/ 2020-05-26T08:13:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/testing-needs-to-be-ramped-up-for-economies-to-re-open/ 2020-05-26T06:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-economies/ 2020-05-26T06:31:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/ptc-acquires-censa/ 2020-05-26T09:13:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sinovac-covid-19-vaccine-funding/ 2020-09-04T12:19:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-brazil-about-to-overtake-russia-with-most-covid-19-cases-after-us-indonesia-reports-a-sharp-rise/ 2020-05-26T06:39:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/flexible-isolator-technology-the-containment-solution-for-pharmaceutical-processing/ 2020-05-22T15:59:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-office-of-national-statistics-puts-excess-death-figure-during-covid-pandemic-at-55000/ 2020-05-22T15:41:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-mckinseys-four-forces-that-will-mould-the-next-normal-us-dol-reveals-more-than-38-million-unemployed/ 2020-05-22T15:32:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-will-accelerate-workplace-automation-say-business-leaders/ 2020-05-22T15:29:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/research-published-in-the-lancet-finds-no-benefit-for-hydroxychloroquine-against-covid-19/ 2020-05-22T14:30:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/fdi/coronavirus-is-changing-fdi-but-is-it-going-to-last/ 2022-03-31T20:07:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/oxford-starts-recruiting-patients-in-phase-ii-iiicovid-19-vaccine-trial/ 2020-05-22T13:07:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uea-pharmaceutical-deals/ 2020-05-22T12:58:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glaxosmithkline-samsung-biologics-deal/ 2021-11-22T14:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atomwise-covid-19-collaborations/ 2020-05-22T09:48:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-5-1-million-brazil-deaths-exceed-20000-australia-extends-ban-on-cruise-ship-visits/ 2020-05-22T08:32:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-atomwise-forms-partnerships-to-develop-broad-spectrum-drug-novalead-to-start-phase-iii-covid-19-trial-in-india/ 2020-05-22T08:17:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/strategic-lockdown-lifting-may-help-economies-recover/ 2020-05-22T07:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/economy-expand-lockdown/ 2020-05-22T06:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-cases-exceed-5-million-increases-continue-in-latin-america-no-new-cases-in-london/ 2020-05-22T06:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/excess-deaths-pandemic-covid-19-fatalities/ 2020-05-21T16:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/beximco-pharma-launches-first-generic-remdesivir-for-covid-19/ 2020-05-21T14:32:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-covid-19-worst-pandemic-driven-economic-impact-since-2000-people-could-be-out-of-work-for-2-3-years/ 2020-05-21T13:14:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beximco-pharmaceuticals-remdesivir-generic/ 2020-09-07T09:10:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/angina-comorbidity-concern-2/ 2022-11-25T17:04:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/angina-comorbidity-concern/ 2020-05-21T13:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telemedicine-most-suitable-areas-during-covid-19/ 2023-08-09T03:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-gets-1bn-from-us-barda-to-support-covid-19-vaccine/ 2020-05-21T09:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-and-infrastructure-a-chance-for-innovation/ 2020-09-18T13:51:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-us-support-covid-vaccine/ 2020-05-21T09:29:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-infections-near-5-million-europe-told-to-brace-itself-for-second-wave-global-trade-lowest-in-four-years-says-wto/ 2020-05-21T08:38:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/rapid-micro-biosystems 2020-05-20T10:43:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-a-second-indian-company-launches-covid-19-vaccine-trial-brighton-and-oxford-hospitals-initiate-a-study-of-hydroxychloroquine-to-prevent-covid-19/ 2020-05-21T08:08:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telemedicine-high-level-usage-post-covid-19/ 2023-02-28T04:53:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-driven-recession-could-impact-2020-graduate-careers-for-a-decade/ 2020-05-21T06:44:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-recession-students/ 2020-05-21T06:30:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inovio-covid-19-vaccine-preclinical/ 2021-11-23T04:25:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-confirmed-covid-19-cases-exceed-4-9-million-record-daily-numbers-of-new-cases-in-south-america/ 2020-05-21T06:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-south-korea-best-prepared-health-services/ 2022-01-19T13:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/atea-receives-215m-funding-and-fda-approval-to-start-phase-ii-covid-19-trial/ 2020-05-20T16:19:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/which-regions-will-benefit-from-a-post-covid-19-reshoring-trend/ 2020-09-18T13:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-global-economy-expected-to-shrink-by-1-9-growth-still-predicted-for-china-and-india/ 2020-05-20T13:19:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/adelyra-to-advance-hsp90-inhibitor-into-clinical-trials-for-covid-19/ 2020-05-20T12:47:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bharat-biotech-covid-19-vaccine/ 2020-05-21T04:10:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-us-gdp-to-contract-by-11-in-q2-eyes-on-chinas-additional-fiscal-support-uk-gdp-downgraded/ 2020-05-20T11:08:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-vividion-therapeutics-deal/ 2020-05-20T11:09:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/abcellera-covid-19 2020-05-21T07:29:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-crisis-drives-companies-to-rethink-global-expansion-strategies/ 2020-05-20T10:04:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/phlow-us-drug-supply-contract/ 2020-05-20T09:43:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-cases-approach-5-million-eu-criticizes-trumps-threat-to-permanently-cut-us-funding-for-the-who/ 2020-05-20T09:02:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/kancera-to-study-hyperinflammation-drug-for-covid-19/ 2020-05-20T09:00:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/experts-express-doubt-about-modernas-vaccine-according-to-stat/ 2020-05-20T08:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-drug-pricing/ 2021-04-07T16:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-australian-researchers-study-hydroxychloroquine-as-a-preventative-treatment-covis-studies-asthma-drug-against-covid-19/ 2020-05-20T07:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/trade-wars-could-result-from-covid-19-driven-economic-downturn/ 2020-05-20T07:27:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/global-trade-wars/ 2020-05-20T07:18:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-exceed-4-8-million-concerns-over-accurate-reporting-in-africa/ 2020-05-20T06:30:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-impact-spain-2/ 2020-05-19T16:01:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-impact-spain/ 2020-05-19T15:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/abbvie-allergan-acquisition-2/ 2020-05-19T15:22:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abbvie-allergan-acquisition/ 2023-03-15T08:48:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/almost-50000-excess-deaths-in-england-and-wales-says-ons/ 2020-05-19T13:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-contact-tracing-app-risks-excluding-those-without-smartphone-access/ 2020-05-19T13:06:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-raises-1-34bn-in-public-offering-to-support-covid-19-vaccine/ 2020-05-19T13:00:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avexis-ec-approval-zolgensma/ 2021-10-21T11:16:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-covid-19-vaccine-vibalogics/ 2020-05-19T10:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-update-unctad-projects-trade-decline-of-27-imf-questions-future-financial-stability-uk-jobseekers-exceed-2-million/ 2020-05-19T10:24:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-report-big-falls-in-covid-19-fatalities-in-europe-global-figures-lag-behind/ 2020-05-19T09:56:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-cases-pass-4-8-million-trump-taking-hydroxychloroquine-imf-says-full-economic-recovery-unlikely-in-2021/ 2020-05-19T08:41:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-government-repatriates-covid-19-generics-manufacturing-with-354m-investment/ 2020-05-19T08:33:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-ema-considering-marketing-authorisation-for-remdesivir-astrazeneca-seeking-vaccine-manufacturing-deals-outside-the-uk/ 2020-05-19T08:08:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-price-gouging/ 2020-12-15T12:18:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-lockdown-increases-online-spending-by-25-100000-stores-could-close/ 2020-05-19T07:03:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/covid-19-online-spending/ 2020-05-19T06:28:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-more-than-4-7-million-cases-of-covid-19-worldwide-concerns-about-rapid-spread-in-brazil/ 2020-05-19T06:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cipla-multi-drug-combo-covid-19/ 2021-10-27T11:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cities-and-regions-update-changes-in-focus-as-lockdowns-ease-illinois-in-us-and-uk-north-west-gain-prominence/ 2020-05-18T15:04:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-publishes-positive-interim-phase-i-results-of-covid-19-vaccine/ 2020-05-18T14:14:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-fda-enhertu-nsclc/ 2020-05-18T13:13:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-to-launch-a-drug-in-a-pandemic-with-immunomedics/ 2020-05-18T13:08:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/launch-a-drug-in-a-pandemic-immunomedics/ 2021-01-01T12:46:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sorrento-covid-19-antibody/ 2020-09-07T12:41:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-covid-19-vaccine-funding/ 2020-05-18T10:31:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-report-some-south-american-countries-seeing-a-rise-in-covid-19-fatalities-worldwide-trend-is-down/ 2020-05-18T10:19:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-us-recovery-could-take-until-the-end-of-2021-job-losses-and-disinflation-the-medium-term-outlook-for-europe/ 2020-05-18T09:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-cases-continue-to-rise-in-brazil-fatalities-fall-in-europe-us-freeze-on-who-payments-continues/ 2020-05-18T08:46:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-govt-invests-131m-into-vmic-in-oxford-to-support-covid-19-vaccine-manufacturing/ 2020-05-18T08:32:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-uk-government-supports-oxford-and-imperials-vaccine-bats-vaccine-is-ready-for-clinical-trials/ 2020-05-18T07:52:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-still-rising-in-the-americas-first-incidents-recorded-in-bangladesh-refugee-camps/ 2020-05-18T05:55:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-business-recovery-three-data-driven-steps/ 2020-05-15T15:34:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/london-job-vacancies-fell-by-23-in-the-week-before-lockdown-easing/ 2020-05-15T15:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/dry-eye-syndrome-late-stage-therapies-2/ 2020-05-15T15:00:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/dry-eye-syndrome-late-stage-therapies/ 2023-03-03T11:22:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-responsible-for-more-than-27-of-uk-care-home-deaths-during-march-and-april-deaths-more-than-double-same-period-2019/ 2020-05-15T12:56:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-adcetris-china-ec-approval/ 2020-05-18T14:57:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-german-economy-faces-biggest-slump-since-ww2-us-employment-shows-largest-decline-since-1948/ 2020-05-15T11:11:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-biobanks-partner-to-improve-turnaround-of-covid-19-samples-for-vaccine-development/ 2020-05-15T11:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/predictive-oncology-covid-19-vaccine/ 2020-05-15T10:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-technology-focus-inactive-ingredients/ 2020-05-15T10:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-report-covid-19-deaths-approach-303000-uk-fatalities-fall-as-us-and-italy-rise/ 2020-05-15T09:39:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/german-vsy-biotechnology-develop-novel-drug-to-treat-covid-19/ 2020-05-15T09:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-sanofi-backtracks-on-early-us-access-to-its-covid-19-vaccine-mayo-clinic-study-shows-convalescent-plasma-is-safe/ 2020-05-15T08:36:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-infections-near-4-5-million-vaccine-row-brewing-bolsonaro-urges-for-lifting-of-lockdown-as-brazil-records-almost-14000-covid-cases-in-a-day/ 2020-05-15T08:35:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-unemployment-could-hit-25-say-experts/ 2020-05-15T06:48:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unemployment-covid-increase/ 2020-05-15T06:30:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-on-the-rise-in-latin-america-total-lockdown-in-chiles-capital/ 2020-05-15T05:59:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-university-covid-19-vaccine-monkey-data/ 2021-03-02T17:35:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/abivax-initiates-large-european-covid-19-trial-of-anti-inflammatory-drug/ 2020-05-14T15:51:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-driven-decline-in-the-jobs-market-may-be-slowing/ 2020-05-14T14:07:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytoagents-nih-funding/ 2020-05-14T12:32:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-cdr-life-deal/ 2020-05-14T10:31:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-report-global-covid-19-deaths-rise-by-more-than-5000-weekly-trend-is-down/ 2020-05-14T09:48:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-covid-19-to-slash-global-economic-output-by-8-5trn-305-million-full-time-jobs-could-be-lost-in-q2/ 2020-05-14T09:10:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-deaths-near-300000-who-warns-virus-could-become-endemic/ 2020-05-14T08:28:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-us-to-get-first-dibs-on-sanofis-covid-19-vaccine-takeda-launches-its-blood-plasma-trials/ 2020-05-14T08:03:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-sees-slowdown-in-covid-19-driven-job-losses-among-lower-paid/ 2020-05-14T06:52:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/stimulus-packages-recession/ 2020-05-14T06:38:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-new-clusters-of-covid-19-as-lockdowns-ease-confirmed-cases-surge-in-brazil/ 2020-05-14T06:23:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-vaccine-us-access/ 2020-05-14T10:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/triplet-combinations-options-complicate-melanoma-treatment/ 2023-02-03T08:55:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/chronic-angina-therapeutic-angiogenesis-2/ 2022-11-25T17:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/chronic-angina-therapeutic-angiogenesis/ 2020-05-13T15:07:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-parallel-export-covid-19-2/ 2020-05-13T13:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uk-parallel-export-covid-19/ 2020-05-13T14:37:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tau-neovii-covid-19-vaccine/ 2020-05-13T12:16:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-to-shake-up-site-selection-decisions/ 2020-09-18T16:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ace2-covid-19-men-2/ 2020-05-13T11:53:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ace2-covid-19-men/ 2020-05-13T11:48:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-remdesivir-licensing-deals/ 2020-09-07T17:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-downturn-sharper-but-shorter-than-2008-says-morgan-stanley-imf-warns-of-catastrophic-consequences-in-sub-saharan-africa/ 2020-05-13T10:18:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-covid-19-vaccine-fast-track/ 2021-06-01T08:55:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-government-launches-covid-19-genomics-project-to-support-clinical-development/ 2020-05-13T09:27:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-deaths-from-covid-19-continue-to-fall-in-most-countries-with-serious-outbreaks-us-still-seeing-highest-number/ 2020-05-13T08:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-pass-4-25-million-niaid-director-warns-us-of-serious-consequences-if-lockdown-eased-too-soon/ 2020-05-13T08:48:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gilead-signs-licensing-agreements-with-5-manufacturers-for-remdesivir-more-international-partnerships-for-covid-19-vaccines/ 2020-05-13T08:44:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-driving-a-fall-in-consumer-price-index-that-could-lead-to-recession-say-economists/ 2020-05-13T07:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cpi/ 2020-05-13T07:02:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-russia-second-highest-in-confirmed-covid-19-cases-india-eases-lockdown-as-infections-rise/ 2020-05-13T06:16:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-receives-fda-fast-track-designation-for-covid-19-vaccine/ 2020-05-12T15:40:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharmaceutical-industry-covid-19-concerns/ 2020-05-12T14:15:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/macroeconomic-forecast-gdp-forecasts-revised-downwards-again-italy-nears-double-digit-decline/ 2020-05-12T13:50:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acer-therapeutics-emetine-covid-19/ 2020-05-12T13:29:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-covid-19-pandemic-could-push-40-60-million-into-extreme-poverty/ 2020-05-12T11:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dyno-therapeutics-gene-therapy-deals/ 2020-05-12T11:06:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/abbvie-allergan-acquisition-63bn 2021-10-28T12:13:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-global-mortality-rate-trending-down-fears-that-trend-could-be-halted-as-lockdowns-ease/ 2020-05-12T09:56:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cepi-novavax-vaccine-covid-19/ 2020-05-12T09:23:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-forces-a-rethink-of-global-supply-chains/ 2022-07-11T08:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-work-on-vaccines-accelerating-trump-declares-victory-new-york-covid-19-deaths-may-be-5000-higher-than-official-figures/ 2020-05-12T09:31:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/nejm-study-finds-hydroxychloroquine-has-no-significant-impact-on-covid-19-outcomes/ 2020-05-12T08:34:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/who-recognises-uks-stabilitech-as-a-covid-19-vaccine-developer/ 2020-05-12T08:24:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-cepi-provides-more-funding-to-novavax-ema-expands-compassionate-use-of-gileads-remdesivir/ 2020-05-12T08:07:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/stimulus-packages-could-bring-higher-taxes-and-debt-post-covid-19-say-economists/ 2020-05-12T07:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/stimulus-covid-19-taxes/ 2020-05-12T07:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-cases-of-covid-19-exceed-4-million-germany-reports-increasing-infections-after-easing-lockdown/ 2020-05-12T07:33:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-digital-health-passport-to-be-supplied-to-15-countries/ 2020-05-11T15:11:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-cities-and-regions-new-cases-continue-to-drop-widespread-easing-of-lockdowns/ 2020-05-11T13:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-regains-brazikumab/ 2020-05-11T12:48:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/unemployment-post-covid-19-must-be-addressed-say-economists/ 2020-05-11T10:43:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/unemployment-covid-19/ 2020-05-11T10:39:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-fda-approval-retevmo/ 2020-05-11T12:44:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-small-businesses-under-pressure-hamada-warns-against-monetary-easing-populist-investments-forecast-to-increase/ 2020-05-11T09:35:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sorrento-covid-19-antibody-cocktail/ 2020-05-11T10:46:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-deaths-showing-a-downward-trend-us-continues-to-record-the-greatest-number/ 2020-05-11T09:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/genocea-cancer-treatment-personalised-targets/ 2020-05-05T09:31:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-uk-cases-2/ 2020-05-11T08:33:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-uk-accord/ 2020-05-12T10:31:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-uk-cases/ 2020-05-11T08:23:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-niaid-launch-trial-combining-remdesivir-with-lilys-baricitinib-university-of-hong-kong-finds-early-promise-in-triple-combination-therapy/ 2020-05-11T11:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-deaths-fall-in-new-york-new-outbreak-in-china-scientists-find-evidence-of-coronavirus-mutations/ 2020-05-11T08:14:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sanofi-regeneron-libtayo-2/ 2020-05-11T08:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sanofi-regeneron-libtayo/ 2021-11-23T08:28:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-exceed-3-8-million-numbers-spike-in-germany-low-uk-recovery-rate-a-concern/ 2020-05-09T08:35:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-transport-status-berlin-milan-madrid-rome-mobility-all-up-london-increasing/ 2020-05-08T11:58:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-recommends-roche-kadcyla/ 2020-05-08T11:20:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fda-authorises-moderna-to-conduct-phase-ii-trial-of-covid-19-vaccine/ 2020-05-08T10:10:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tonix-pharmaceuticals-covid-19-vaccines/ 2020-05-08T10:01:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-rescue-packages-risk-years-of-public-debt-say-economists/ 2020-05-08T08:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/public-debt-covid/ 2020-05-08T07:45:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-almost-88000-new-covid-19-cases-lockdowns-easing-new-cases-surge/ 2020-05-08T07:26:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/japanese-regulator-approves-gileads-remdesivir-to-treat-covid-19/ 2020-05-08T07:16:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-remdesivir-approval-japan/ 2020-05-08T05:58:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-treatment-ifpma/ 2020-05-07T09:50:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/magenta-therapeutics-avrobio-evaluate-mgta-117/ 2020-05-07T13:25:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/healthcare-organisations-are-being-targeted-by-state-backed-hackers-governments-warn/ 2022-02-03T09:07:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/protease-inhibitors-covid-19-abbvie-ascletis-2/ 2020-05-07T10:31:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/protease-inhibitors-covid-19-abbvie-ascletis/ 2020-05-07T10:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-us-deaths-highest-for-two-weeks-global-trend-is-down/ 2020-05-07T09:44:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/pharma-spin-out-2020 2020-04-29T10:51:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-bank-of-england-predicts-uk-gdp-to-drop-nearly-30-in-q2-deloitte-say-mass-unemployment-could-reduce-wages/ 2020-05-07T09:14:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderate-inflation-can-help-in-dealing-with-the-huge-debt-created-by-covid-19-say-economists/ 2020-05-07T08:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inflation-covid/ 2020-05-07T08:47:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/vertex-affinia-gene-therapy 2020-05-06T14:46:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-astrazenecas-farxiga-cv-death/ 2020-05-07T08:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-3-75-million-confirmed-cases-of-covid-19-globally-who-warns-of-risks-of-emerging-from-pandemic-restrictions/ 2020-05-07T08:14:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gilead-looking-to-scale-up-remdesivir-manufacturing-india-produces-guidelines-on-off-label-use-of-hiv-drugs-for-covid-19/ 2020-05-07T07:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-uk-has-highest-covid-19-case-fatality-rate-of-ten-most-affected-countries-more-than-double-the-global-rate/ 2020-05-07T06:41:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csir-sepsis-drug-covid-19-vaccine/ 2022-02-23T05:52:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/transthyretin-amyloidosis-market/ 2023-01-04T11:29:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/in-only-six-weeks-twist-identified-monoclonal-antibodies-to-form-basis-of-covid-19-therapies/ 2020-05-06T13:42:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/precisionlife-identifies-59-drugs-to-improve-survival-in-covid-19-patients-who-develop-sepsis/ 2022-02-23T05:53:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-deaths-in-stable-decline-in-most-global-hotspots-us-has-some-way-to-go/ 2020-05-06T13:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-pandemic-ms-treatment-2/ 2020-05-06T12:40:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-pandemic-ms-treatment/ 2020-05-06T12:40:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alexion-buys-portola-pharmaceuticals/ 2021-11-22T13:00:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/csl-behring-australia-joins-race-for-covid-19-therapy-development/ 2020-05-06T10:44:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-behring-australia-covid-19-therapeutic/ 2020-05-06T10:34:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-lockdown-risks-surge-in-tb-covid-19-cases-pass-3-65-million-us-fatalities-exceed-70000/ 2020-05-06T09:31:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-uk-worst-hit-in-europe-as-deaths-approach-30000-global-figure-exceeds-257000/ 2020-05-06T09:20:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/advance-market-commitments-needed-to-develop-covid-19-vaccine-say-macroeconomic-influencers/ 2020-05-06T08:46:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-vaccine-lockdown/ 2020-05-06T08:42:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/zejula-lynparza-ovarian-cancer-2/ 2020-05-06T08:29:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-novartis-and-incyte-to-launch-second-phase-iii-trial-of-jakafi-gilead-to-ramp-up-manufacturing-capacity-for-remdesivir/ 2020-05-06T08:24:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/zejula-lynparza-ovarian-cancer/ 2020-05-06T08:22:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-reduction-of-covid-cases-in-europe-continues-sharp-rise-in-india-amid-concerns-of-management-response/ 2020-05-06T05:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/italy-coronavirus-vaccine-candidate/ 2020-09-07T06:07:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/london-tech-recruitment-slumps-57-during-pandemic/ 2020-05-05T17:10:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-uk-now-has-the-highest-coronavirus-death-toll-in-europe/ 2020-05-05T17:08:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pharma-mcap-q1-2020-2/ 2020-05-05T14:44:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-mcap-q1-2020/ 2020-05-05T14:41:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-forecast-western-nations-revised-downwards-again-uk-drop-off-particularly-steep/ 2020-05-05T14:35:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-global-death-toll-passes-250000-us-outbreak-projected-to-accelerate-135000-deaths-predicted/ 2020-05-05T13:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-and-biontech-dose-first-patients-in-us-covid-19-vaccine-trial/ 2020-05-05T12:42:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/menarini-buys-stemline-therapeutics/ 2020-05-05T12:37:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/cross-border-dealmaking-dwindles-as-economies-are-hit-by-coronavirus-pandemic/ 2022-03-31T20:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/nearly-40000-more-deaths-than-normal-since-the-start-of-covid-19-outbreak-in-england-and-wales-says-ons/ 2020-05-05T13:52:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-junshi-biosciences-covid-19-deal/ 2020-05-05T10:41:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-global-deaths-down-week-on-week-confirmed-cases-rise-by-more-than-76000/ 2020-05-05T10:16:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economics-round-up-frankel-warns-against-w-shaped-recession-jp-morgan-predict-u-shaped-mckinsey-call-for-business-urgency/ 2020-05-05T09:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/federal-job-guarantee-can-avoid-mass-unemployment-amid-covid-19-macroeconomic-influencers/ 2020-05-05T08:47:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inactive-ingredients-allergens/ 2020-04-28T20:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-world-leaders-pledge-8bn-to-covid-19-efforts-catalent-signs-another-coronavirus-manufacturing-agreement/ 2020-05-05T08:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/unemployment-covid-influencers/ 2020-05-05T08:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-global-covid-19-cases-pass-3-5-million-fatalities-approach-250000-sharp-rise-of-cases-in-russia/ 2020-05-05T06:43:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/new-sars-cov-2-antibody/ 2020-09-07T15:30:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vir-and-alnylam-partner-on-developing-rnai-covid-19-drug/ 2020-05-04T16:08:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-value-of-real-world-evidence-during-the-covid-19-outbreak-2/ 2020-05-04T14:19:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/the-value-of-real-world-evidence-during-the-covid-19-outbreak/ 2020-05-04T14:14:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-cities-and-regions-cases-falling-in-major-cities-around-the-world-us-still-behind-the-curve/ 2020-05-04T13:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaxxel-buys-transgene-cell-line/ 2020-05-04T13:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-canada-funding-covid-19/ 2020-05-04T10:27:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economics-round-up-us-unemployment-claims-pass-30-million-global-gdp-in-decline-earnings-estimates-down-20/ 2020-05-04T10:10:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/big-pharma-vc-forx 2020-05-04T10:03:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-climate-change/ 2020-05-04T08:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-global-deaths-dropping-slowly-us-still-recording-daily-deaths-in-four-figures/ 2020-05-04T08:50:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vaccination-against-covid-19-estimated-to-cost-more-than-20bn-say-leading-macroeconomic-influencers/ 2020-05-04T08:31:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/vaccination-against-covid/ 2020-05-04T08:21:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-remedesivir-receives-eua-from-the-fda-canadian-government-to-spend-175-6m-on-abcellaras-antibody-drugs/ 2020-05-04T08:56:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-vaccine-still-elusive-japan-to-ride-out-covid-19-upsurge-surveys-need-more-study-before-easing-lockdowns/ 2020-05-04T07:22:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-remdesivir-eua-covid-19/ 2020-05-04T07:16:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/covid-top-tweet/ 2023-03-15T10:36:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-comoros-east-africa-latest-country-to-register-covid-19-global-recoveries-pass-1-million/ 2020-05-03T15:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gileads-remdesivir-use-for-covid-19-could-spill-over-beyond-sweet-spot-of-hospitalised-patients-yet-to-require-mechanical-ventilation/ 2020-05-04T08:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/japan-covid-19-outbreak-2/ 2020-05-04T07:52:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/japan-covid-19-outbreak/ 2020-05-01T17:38:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/survey-results-social-restrictions/ 2020-05-04T07:54:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/preliminary-antibody-survey/ 2020-05-01T15:43:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/who-and-eib-expand-commitment-to-reduce-impact-of-covid-19-and-future-emergencies/ 2020-05-01T15:05:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/market-cap-growth-biopharma-covid-19-2/ 2020-05-04T07:57:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-cap-growth-biopharma-covid-19/ 2020-05-01T16:14:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-treatment-vaccine/ 2020-05-01T14:32:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/amgen-to-study-anti-inflammatory-drug-otezla-against-covid-19/ 2020-05-01T14:32:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-treatment-remains-elusive/ 2020-05-01T14:23:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-single-use-fibc-containment-systems-can-work-for-you/ 2020-05-22T15:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/moderna-signs-manufacturing-agreement-for-to-scale-covid-19-vaccine-production/ 2020-05-01T13:46:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/incyte-eli-lilly-jak-inhibitor-covid-19-2/ 2020-05-01T13:24:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/mobility-update-traffic-on-the-move-ahead-of-lockdowns-being-lifted-berlin-shows-biggest-increase/ 2020-05-01T13:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/incyte-eli-lilly-jak-inhibitor-covid-19/ 2020-05-01T13:18:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-lonza-manufacturing-deal/ 2021-10-21T09:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-eu-sees-sharpest-gdp-decline-as-7-4-unemployment-rate-recorded-em-capital-flows-bad-news-but-not-catastrophic/ 2020-05-01T12:07:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-coronavirus-deaths-on-a-downward-trend-in-europe-us-has-more-than-2000-deaths-for-third-consecutive-day/ 2020-05-01T11:31:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-pfizer-lyme-disease-vaccine/ 2020-05-01T10:46:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inovio-covid-19-vaccine-production/ 2021-11-22T08:23:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/free-zones-the-breeding-ground-for-economic-recuperation/ 2020-09-18T16:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/idiopathic-thrombocytopenic-purpura-asia-pacific-2/ 2020-05-01T08:58:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/idiopathic-thrombocytopenic-purpura-asia-pacific/ 2023-05-09T07:16:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/women-accounted-for-majority-of-the-30-million-workers-who-filed-for-unemployment-benefits-in-the-us-in-the-last-two-months/ 2020-05-01T08:50:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/women-unemployment/ 2020-05-01T08:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/company-coronavirus-news-summary-clinical-trials-of-favipiravir-to-begin-in-india-uc-san-diego-to-study-hypertension-drug-for-covid-19-gilead-and-pfizer-to-boost-manufacturing/ 2020-05-01T08:22:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-mrna-based-vaccine-2/ 2020-05-01T07:42:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-mrna-based-vaccine/ 2020-09-04T06:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-recruitment-difficulties-for-covid-19-drug-treatment-trials-kevzara-preliminary-results-announced/ 2020-05-01T07:19:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-now-in-188-countries-recovered-cases-approach-1-million/ 2020-05-01T06:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sanofi-kevzara-trial-covid-19-2/ 2020-04-30T15:34:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sanofi-kevzara-trial-covid-19/ 2020-04-30T15:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fujifilm-biotech-reserves-manufacturing-space-for-gates-foundations-covid-19-accelerator/ 2020-04-30T15:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/coronavirus-affected-countries-india-measures-impact-pharma-economy/ 2023-03-16T09:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-covid-19-puts-1-6-billion-jobs-at-risk-q1-company-earnings-most-watched-in-history-say-goldman-sachs/ 2020-04-30T13:14:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-fda-approval-zejula-ovarian-cancer/ 2020-04-30T12:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/automotive-jobs-slump-as-world-economy-takes-a-covid-19-hit/ 2020-04-30T11:55:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atreca-beigene-igm-bio-covid-19/ 2021-11-23T12:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gdp-of-majority-of-the-economies-to-be-below-pre-covid-19-levels-for-two-to-three-years/ 2020-04-30T10:47:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/gdp-pandemic/ 2020-04-30T10:50:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-govt-financially-supports-gavis-efforts-for-universal-access-to-a-covid-19-vaccine/ 2020-04-30T10:25:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-and-oxford-university-partner-on-covid-19-vaccine/ 2020-04-30T10:53:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-deaths-pass-225000-inflammatory-syndrome-in-children-linked-to-coronavirus-us-deaths-pass-60000/ 2020-04-30T09:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-oxford-covid-19-vaccine/ 2020-04-30T09:47:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/label-update-sglt2-is-inhibitors-fda-safety-review/ 2020-04-30T09:08:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/universal-cancer-treatment-peptomyc/ 2020-04-24T13:16:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gileads-remdesivir-meets-endpoint-in-niaid-study-pfizer-biontech-commence-dosing-in-vaccine-study/ 2020-04-30T08:21:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-now-affects-187-countries-over-1-million-cases-in-us/ 2020-04-30T06:36:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/niaid-trial-remdesivir-covid-19-data/ 2020-04-30T08:47:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/up-to-one-in-17-uk-care-home-residents-have-died-in-five-weeks-since-the-start-of-the-covid-19-outbreak/ 2020-04-29T18:39:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/investment-in-uk-startups-hit-663m-in-first-month-of-lockdown-led-by-tech-sector/ 2020-04-29T15:03:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-economy-falls-by-4-8/ 2020-04-29T14:38:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/european-investment-bank-collaborates-with-cepi/ 2020-04-29T13:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-businesses-warned-of-recession-worse-that-the-great-depression-oil-prices-to-bounce-back-rising-debts-to-slow-recovery/ 2020-04-29T13:34:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uq-covid-19-vaccine-preclinical-data/ 2020-04-29T13:05:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-covid-19-cases-pass-1-million-russia-to-remain-in-lockdown-as-cases-surpass-chinas/ 2020-04-29T12:10:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-covid-19-chart-downward-path-from-peak-death-rate-is-slow-italy-in-stable-decline-uk-erratic/ 2020-04-29T11:34:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-covid-19-drugs-vaccine/ 2020-04-29T10:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pneumagen-in-vitro-covid-19-data/ 2020-04-29T09:53:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-government-launches-platform-to-fast-track-drugs-into-covid-19-trials/ 2020-04-29T09:18:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-daily-deaths-rise-in-us-italy-and-uk-but-over-all-trend-is-downward/ 2020-04-29T08:50:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-pandemic-how-modelling-can-support-drug-development/ 2020-04-29T08:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid19-modelling-drug-development/ 2020-04-29T08:34:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-shionogi-joins-research-efforts-against-covid-19-roches-actemra-performs-well-in-severe-patients/ 2020-04-29T08:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-new-parkinsons-drug-launch-delayed-covid-pandemic-could-increase-levels-of-ptsd/ 2020-04-29T07:33:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-in-brazil-exceed-66000-us-spain-and-italy-have-most-reported-cases/ 2020-04-29T06:55:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/race-intensifies-covid19-vaccine-html/ 2022-02-22T09:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-to-build-a-secure-remote-working-organisation/ 2020-04-28T17:00:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/italy-cmos-covid-19-2/ 2020-04-28T16:40:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/italy-cmos-covid-19/ 2021-10-27T12:24:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/age-related-macular-degeneration/ 2020-04-29T08:58:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/macular-degeneration-cases/ 2020-04-28T16:11:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uq-vaccine-demonstrates-good-immune-response-in-pre-clinical-models/ 2020-04-28T14:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-gdp-growth-forecasts-for-eu-and-india-worsen-uniro-says-covid-19-will-leave-a-legacy-for-years-to-come/ 2020-04-28T14:14:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/neurocrine-parkinsons-drug-covid-19-2/ 2020-04-28T13:21:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/neurocrine-parkinsons-drug-covid-19/ 2020-04-28T13:17:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-economic-forecast-gdp-major-western-nations-all-down-italy-to-see-drop-of-more-than-8/ 2020-04-28T13:00:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/takeda-orifarm-deal-divestiture 2020-04-28T12:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kamada-kedrion-covid-19-therapy/ 2020-04-28T12:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ptsd-covid-19-2/ 2020-04-28T12:02:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ptsd-covid-19/ 2020-04-28T11:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-isb-covid-19-research/ 2021-12-07T08:07:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/clover-biopharmaceuticals-cepi-funds/ 2020-04-28T10:17:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/from-covid-19-to-sars-what-becomes-of-the-whistleblowers/ 2020-04-28T09:52:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-who-say-pandemic-far-from-over-chinas-top-scientists-novel-coronavirus-will-not-be-eradicated/ 2020-04-28T09:32:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pharma-fdi-in-the-times-of-covid-19-a-challenging-pill-to-swallow-2/ 2020-09-18T16:13:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-fdi-in-the-times-of-covid-19-a-challenging-pill-to-swallow/ 2020-06-24T04:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-confirmed-cases-top-3-million-new-cases-in-stable-decline/ 2020-04-28T08:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-whistleblowers/ 2020-05-04T08:52:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-gileads-remdesivir-likely-to-receive-rapid-approval-in-japan-moderna-hopes-to-advance-covid-19-vaccine-to-phase-ii-cepi-funds-its-ninth-vaccine-candidate/ 2020-04-28T08:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-established-drugs-join-expanding-trials-list-serology-tests-needed-to-ease-lockdowns/ 2020-04-28T07:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-globally-confirmed-cases-approach-3-million-recovered-patients-testing-positive-for-second-time/ 2020-04-28T06:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/viiv-commits-3m-to-research-and-mitigate-impact-of-covid-19-on-hiv-patients/ 2020-04-27T14:40:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ards-treatment-covid-19-2/ 2020-04-27T14:31:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ards-treatment-covid-19/ 2021-11-22T06:14:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/regeneron-sanofis-kevzara-trial-narrowed-to-critical-covid-19-patients-only/ 2020-04-27T14:00:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-update-covid-19-cases-falling-in-madrid-london-and-milan-new-york-still-accounts-for-30-of-us-cases/ 2020-04-27T13:39:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-cshl-lonodelestat-covid-19/ 2020-04-27T10:20:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-global-covid-19-cases-approach-3-million-france-italy-and-spain-announce-easing-of-lockdowns/ 2020-04-27T10:16:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gates-foundation-reorientates-to-exclusively-focus-on-covid-19/ 2020-04-27T09:32:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-bank-of-japan-says-future-developments-extremely-unclear-slower-recovery-predicted-for-uk/ 2020-04-27T09:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fda-approval-menquadfi/ 2020-04-27T09:29:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/roches-actemra-sales-jump-amid-testing-in-severe-covid-19-patients/ 2020-04-27T09:24:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/actemra-sales-severe-covid-19/ 2020-04-27T09:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/social-trust-key-to-beating-the-covid-19-pandemic/ 2020-04-27T09:04:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scancell-covid-19-dna-vaccine/ 2020-04-27T08:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/social-trust-macroeconomic-influencers/ 2020-04-27T08:42:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/global-leaders-commit-to-equitable-access-to-covid-19-treatments-and-vaccine/ 2020-04-27T09:21:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/mumps-vaccines/ 2020-04-24T08:56:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-china-progresses-a-second-vaccine-candidate-into-phase-ii-uk-government-launches-plasma-therapy-clinical-trial/ 2020-04-27T08:09:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdi-in-a-pandemic-how-low-will-the-inflows-go/ 2020-09-18T16:45:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-more-than-191000-deaths-globally-international-concern-over-growing-number-of-possibly-infectious-asymptomatic-cases/ 2020-04-25T16:17:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/biotechs-testing-for-covid-19-in-asia-pacific-benefit-from-new-fast-track-review-processes/ 2024-03-05T17:14:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-frontier-markets-yet-to-feel-impact-of-covid-19-commodity-markets-could-see-long-term-changes/ 2020-04-24T12:06:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/affinivax-120m-funding-round/ 2020-04-24T11:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-sells-products-orifarm/ 2020-04-24T10:53:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-janssen-emergent-biosolutions-vaccine/ 2021-12-02T12:09:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-cardiac-injury-can-occur-in-those-with-no-previous-risk-bcg-vaccination-may-offer-heterologous-immunity/ 2020-04-24T11:56:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gilead-says-leaked-covid-19-trial-data-of-remdesivir-inconclusive/ 2020-04-24T09:46:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-pandemic-expected-to-create-massive-inequality-and-high-unemployment/ 2020-04-24T09:49:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-us-deaths-top-50000-trump-suggests-injecting-disinfectants/ 2020-04-24T09:06:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-worrying-results-for-remdesivir-inconclusive-according-to-gilead-first-two-patients-dosed-in-university-of-oxford-vaccine-trial/ 2020-04-24T08:11:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/ex-barda-chief-claims-was-ousted-over-opposition-to-hydroxychloroquine/ 2020-04-24T08:03:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-report-covid-19-cases-exceed-2-6-million-consecutive-days-decrease-for-italy/ 2020-04-24T07:31:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/inequality-deprivation/ 2020-04-24T07:28:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-remdesivir-covid-19-china-data/ 2020-04-24T07:32:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/is-the-us-ready-to-start-relaxing-covid19-lockdowns-html/ 2021-11-02T03:19:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/niaid-lays-out-its-four-covid-19-research-priorities/ 2020-04-23T15:42:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/bcg-vaccination-may-induce-heterologous-immunity-and-protect-against-covid-19/ 2020-04-23T15:38:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bcg-vaccination-covid-19/ 2020-09-04T08:03:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/research-into-transmission-of-covid-19-could-support-drug-development/ 2020-04-23T15:07:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/global-jobs-market-continues-downwards-trend-in-covid-19-lockdown/ 2020-04-24T06:56:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/griffith-university-and-iil-team-up-to-develop-covid-19-vaccine/ 2020-04-29T09:02:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/griffith-university-iil-covid-19-vaccine/ 2020-04-23T12:11:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-starts-covid-19-trial-of-diabetes-drug-farxiga/ 2020-04-29T09:03:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/treatment-of-cardiovascular-disease-during-the-covid-19-pandemic/ 2020-04-23T11:25:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/treatment-cardiovascular-disease-covid-19/ 2020-04-23T15:02:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-gdp-reduction-twice-as-severe-as-2009-prolonged-recession-best-case-scenario/ 2020-04-23T11:20:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gordon-brown-on-economic-crises-the-retreat-from-globalisation-and-the-fight-against-covid-19/ 2020-04-23T10:58:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-pope-calls-for-unity-nobel-prize-winner-slams-trump-irc-warns-covid-19-deaths-could-overwhelm-handling-capacity/ 2020-04-23T10:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aj-vaccines-picovax-polio-vaccine/ 2023-05-24T04:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-pharmacists-have-been-unable-to-maintain-social-distancing-during-the-coronavirus-pandemic/ 2020-04-23T09:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/beyond-testing-importance-of-antibody-based-drugs-against-covid-19/ 2020-04-23T09:35:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/antibodies-covid-19-beyond-testing-drug-development/ 2020-04-23T15:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pan-european-consortium-collaborates-on-adenoviral-vector-covid-19-vaccine/ 2020-04-23T08:35:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cereno-scientific-looks-to-enter-pah-market-with-its-leading-product-cs-1/ 2020-04-23T08:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cereno-scientific-cs1-pah/ 2020-04-23T08:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-pharmaceutical-companies-impact-2/ 2020-04-23T08:17:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-imperial-joins-the-covid-19-vaccine-race-mits-vaccine-candidate-enters-pre-clinical-development/ 2020-04-23T08:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-pharmaceutical-companies-impact/ 2024-05-10T07:12:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/stimulus-packages-needed-to-recover-economies-say-leading-macroeconomic-influencers/ 2020-04-23T08:09:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/stimulus-packages-key-to-recovery-from-covid-19-impact-according-to-leading-macroeconomic-influencers/ 2020-04-23T07:54:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-daily-update-around-2-6-million-confirmed-covid-19-cases-new-outbreaks-in-singapore-and-china/ 2020-04-23T07:14:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mit-covid-19-vaccine-candidate/ 2020-04-23T07:13:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/study-finds-hydroxychloroquine-to-have-no-benefit-in-covid-19/ 2020-04-23T07:19:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cancer-drug-shortages-covid-19-2/ 2020-04-22T14:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cancer-drug-shortages-covid-19/ 2020-04-22T14:18:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-coronavirus-pandemic-shows-why-the-west-must-transform-its-economic-logic/ 2020-04-22T13:18:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lack-of-awareness-biggest-challenge-to-telemedicine-adoption-covid-19/ 2020-04-22T11:05:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-equities-rallying-economic-output-to-remain-lower-for-some-time-post-covid-19/ 2020-04-22T12:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-kymriah-fda-rmat/ 2020-04-22T11:50:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-pipeline-drug-companies-funding-2/ 2020-04-22T11:46:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/biontech-and-pfizer-get-german-nod-for-covid-19-vaccine-trial/ 2020-04-22T11:46:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/poll-telemedicine-to-play-a-very-important-role-in-fighting-covid-19/ 2020-04-22T12:25:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-pipeline-drug-companies-funding/ 2020-04-22T11:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/daily-report-world-covid-19-fatalities-trend-suggests-peak-has-been-passed-but-not-in-the-us/ 2020-04-22T12:17:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telemedicine-role-covid-19-pandemic/ 2022-06-13T11:34:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-panel-hydroxychloroquine/ 2020-04-22T10:46:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emerging-technologies-for-covid-19-management-real-world-evidence/ 2020-04-22T10:42:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-death-toll-exceeds-175000-un-warns-of-famines-of-biblical-proportions/ 2020-04-22T09:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/high-risk-of-serious-covid-19-outcomes-for-27-million-severely-obese/ 2020-04-22T10:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/calls-for-covid-19-lockdowns-to-be-lifted-to-aid-economic-recovery/ 2020-04-22T10:25:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-fast-tracks-manufacturing-centre-to-support-covid-19-vaccine/ 2020-04-22T09:13:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/obesity-covid-19-risk-2/ 2020-04-22T08:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/obesity-covid-19-risk/ 2020-09-07T15:26:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-lockdown-restrictions/ 2020-04-22T08:32:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-nih-panel-warns-against-use-of-hydroxychloroquine-karyopharms-multiple-myeloma-drug-investigated-against-covid-19/ 2020-04-22T08:28:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-daily-update-covid-19-cases-slowing-in-italy-global-deaths-exceed-170000/ 2020-04-22T07:12:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/som-biotech-covid-19-candidates/ 2020-04-22T05:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/asia-pacific-witnesses-5-4-increase-in-deal-activity-during-week-ended-19-april-2020 2020-04-21T15:23:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/cerevance-gv-bill-gates 2020-04-21T15:13:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redhill-biopharma-covid-19-drug-candidate/ 2020-04-21T13:00:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vaxart-progresses-oral-covid-19-vaccine-into-clinical-trials/ 2020-04-21T12:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-warning-of-double-digit-us-recession-with-rebound-in-q1-2021/ 2020-04-21T11:05:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ema-review-ocrevus/ 2020-04-21T10:44:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-death-toll-exceeds-170000-who-says-worst-is-yet-to-come/ 2020-04-21T10:17:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-global-daily-deaths-fall-to-lowest-level-in-two-weeks/ 2020-04-21T09:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/beat19-collects-important-data-from-covid-19-patients-recovering-at-home/ 2020-04-21T08:59:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-daily-update-new-covid-19-cases-declining-globally-turkey-russia-and-brazil-report-increases/ 2020-04-21T08:23:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-redhill-investigates-second-candidate-against-covid-19-ec-sets-up-a-european-covid-19-data-database-university-of-georgia-vet-school-develop-a-vaccine/ 2020-04-21T08:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-two-thirds-of-cases-may-be-undiagnosed-pandemic-impacting-on-clinical-trials-in-neurology/ 2020-04-21T07:46:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/advanced-and-developing-economies-both-severely-affected-due-to-covid-19-according-to-leading-macroeconomic-influencers/ 2020-04-21T07:43:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uga-covid-19-vaccine-candidate/ 2020-04-21T05:50:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/pricing-and-market-access/covid19-delays-price-framework-agreements-europe-html/ 2021-11-02T03:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/tips-for-scaling-up-vpns-to-meet-the-remote-working-surge/ 2020-04-20T15:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/155-and-79-vaccines-in-development-for-covid-19/ 2020-04-22T14:28:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/future-fund-the-tech-sector-reacts-to-uk-chancellors-plans-to-help-startups/ 2020-04-20T15:10:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-undiagnosed-cases/ 2020-04-20T13:32:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-59-million-jobs-at-risk-in-europe-growth-in-asia-expected-to-stall/ 2020-04-20T13:11:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/latest-figures-confirm-new-york-state-as-world-epicentre-of-covid-19/ 2020-04-20T12:04:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/remdesivir-shows-promise-covid-monkeys/ 2020-09-07T16:13:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/novartis-moves-to-study-hydroxychloroquine-for-covid-19/ 2020-04-20T11:26:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/influencers-dashboards/a-deeper-recession-and-slow-recovery-predicted-by-leading-macroeconomic-influencers/ 2020-04-20T11:07:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-buys-amblyotech/ 2020-04-20T11:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nih-ppp-covid-19-drugs-vaccine/ 2020-04-20T09:32:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-global-death-toll-approaches-165000-infections-near-2-5-million/ 2020-04-20T09:20:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-europe-death-toll-trending-down-rise-continues-in-us/ 2020-04-20T08:51:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/proteus-smart-pills/ 2020-04-20T08:29:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-job-types-are-affecting-the-covid-19-lockdown/ 2020-04-20T11:07:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-nih-coordinates-high-level-international-public-private-partnership-gileads-remdesivir-shown-to-be-effective-in-monkeys-incyte-and-novartis-study-jak1-2-inhibi/ 2020-04-20T08:05:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-ruxolitinib-covid-19-trial/ 2022-07-11T08:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-daily-update-covid-19-death-toll-nears-145000-cases-on-the-increase-in-belgium/ 2020-04-18T09:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-ibd-risks/ 2020-04-17T19:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/uk-government-launches-covid-19-vaccine-taskforce-to-coordinate-efforts/ 2020-04-17T17:10:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-mental-health-challenges-are-really-significant-how-the-switch-to-remote-working-is-impacting-wellbeing/ 2020-04-17T14:19:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/consortium-investigates-potential-new-therapeutic-approach-for-severe-covid-19/ 2020-04-17T13:34:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-covid-19-lockdown-hong-kong-and-seoul-the-only-world-capitals-moving-at-anything-like-normal-levels-europe-and-north-america-at-a-standstill/ 2020-04-17T15:47:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-haemophilia-index-2020/ 2020-04-17T11:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-warning-over-covid-19-impact-on-emerging-economies-latin-america-faces-a-lost-decade-africa-needs-massive-donor-support/ 2020-04-17T12:20:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/barda-moderna-covid-19-vaccine/ 2020-04-17T10:31:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-death-toll-surges-as-us-begins-to-count-probable-cases/ 2020-04-17T10:20:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-is-undertaking-the-most-clinical-covid-19-studies-according-to-finbolds-index/ 2020-04-17T09:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-covid-19-fatalities-exceed-145000-japan-declares-nationwide-state-of-emergency-president-trump-issues-guidelines-for-reopening-the-us/ 2020-04-17T09:11:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-daily-update-covid-19-case-numbers-rise-in-spain-france-and-uk-extend-lockdown/ 2020-04-17T08:21:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-8/ 2020-04-17T09:40:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/university-of-waterloo-to-develop-nasal-vaccine-for-covid-19/ 2020-04-17T08:31:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/canada-covid-19-vaccine-development/ 2021-03-04T16:21:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/global-deal-activity-decreases-17-2-with-899-deals-last-week 2020-04-16T15:50:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/elsevier-partners-with-exactcure-to-predict-pharmacokinetics-of-repurposed-drugs/ 2020-04-16T16:40:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/coronavirus-mers-cov-drugs/ 2022-10-07T11:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/coronavirus-outbreak-the-countries-affected/ 2022-07-22T10:35:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sweden-covid-19-measures/ 2020-04-16T14:11:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/viiv-hiv-cure-treatment/ 2020-09-07T13:59:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-tagrisso-clinical-trial-stoppage/ 2022-07-11T08:53:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/economic-outlook-cautious-optimism-from-banks-but-imf-reports-a-double-whammy/ 2020-04-16T12:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/jobs-in-every-sector-hit-as-covid-19-downturn-effect-spreads/ 2020-04-16T13:39:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/men-the-elderly-and-people-with-pre-existing-conditions-most-likely-to-die-due-to-coronavirus-official-data-confirms/ 2020-04-16T12:01:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/smc-accepts-stelara-nhs-use/ 2020-04-16T11:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-spread-concern-index/ 2020-04-16T11:51:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-four-contests-that-will-shape-the-post-covid-19-world/ 2020-04-16T12:57:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-update-confirmed-global-covid-19-cases-top-two-million-new-york-city-revises-death-toll-to-10000/ 2020-04-16T11:05:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/high-containment-for-lyophilisation-processes/ 2020-04-16T12:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-treatment-poll-majority/ 2020-04-16T14:25:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tscan-novartis-cancer-therapies-deal/ 2020-04-16T10:16:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/bold-therapeutics-uni-of-ottawa-to-research-anti-viral-drug-for-covid-19/ 2020-04-16T09:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-avigan-production-covid-19/ 2020-04-16T09:44:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/the-endpandemic-data-consortium-gains-six-partners/ 2020-04-16T09:32:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-daily-report-cases-rise-again-after-holiday-weekend/ 2020-04-16T09:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-vaccine-availability-poll/ 2020-04-16T14:22:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-7/ 2020-04-16T09:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/globaldata-epidemiologist-daily-update-covid-19-cases-pass-two-million/ 2020-04-16T09:19:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-companies-optimistic-about-growth-poll/ 2020-06-09T07:23:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/aligos-to-leverage-luxnas-tech-to-create-anti-viral-drugs/ 2020-04-16T09:20:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/number-of-covid-19-cases-reaches-two-million-globally/ 2020-04-15T16:24:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-layoffs-expected-by-almost-half-of-companies/ 2020-04-15T16:06:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/features/blackstone-2bn-alnylam-deal 2020-04-15T15:54:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-koselugo-nf1-fda-approval/ 2020-04-15T13:48:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/applied-dna-ships-covid-19-vaccine-candidates/ 2020-04-15T12:25:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-medicine-boehringer-ai-deal/ 2020-04-15T10:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-third-most-funded-infectious-disease-over-past-five-years/ 2020-04-15T10:18:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/upward-turn-in-covid-19-fatalities-trend-fosters-doubt-that-peak-has-been-reached/ 2020-04-15T14:24:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-covid-19-fatalities-surge-global-death-toll-passes-125000/ 2020-04-15T10:59:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nantkwest-covid-19-vaccines-drugs/ 2020-04-15T09:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/medicines-in-transit-ups/ 2020-04-15T07:56:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-6/ 2020-04-15T12:48:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/epidemiologist-daily-update-5/ 2020-04-15T08:07:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/government-and-policy-update-from-the-new-statesman-6/ 2020-04-15T08:00:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update-2/ 2020-04-15T07:18:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gilead-remdesivir-covid-19/ 2020-09-07T15:46:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/how-european-mayors-are-tackling-economic-crises-in-their-cities/ 2020-04-15T14:26:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/living-with-a-pandemic-how-networks-can-support-the-transition-to-a-new-normal/ 2020-04-14T16:32:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/slight-lift-in-long-term-economic-gloom-amid-easing-of-covid-19-case-rise/ 2020-04-15T08:11:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/exploring-the-hype-around-anti-malarial-hydroxychloroquine/ 2020-04-14T14:08:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/jj-q1-results-financial-strength-to-fight-covid-19/ 2020-04-14T14:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/covid-19-hydroxychloroquine-hype/ 2020-04-23T12:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sanofi-and-gsk-partner-to-develop-covid-19-vaccine/ 2020-04-14T13:23:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-gsk-covid-vaccine/ 2020-04-14T13:03:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blacstone-alnylam-financing-deal/ 2021-11-22T06:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/astrazeneca-to-trial-calquence-to-treat-covid-19-patients/ 2020-04-14T11:24:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/protease-inhibitors-covid-19/ 2020-04-14T10:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-calquence-covid-19-trial/ 2022-07-11T08:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-spread-showing-signs-of-slowing/ 2020-04-15T08:13:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-identifies-covid-19-antibodies/ 2020-04-14T09:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/government-and-policy-update-from-the-new-statesman-5/ 2020-04-14T10:19:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-5/ 2020-04-14T08:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/government-and-policy-update-from-the-new-statesman-4/ 2020-04-15T07:51:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/epidemiologist-daily-update-4/ 2020-04-13T14:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/sanofi-commits-100-million-doses-of-hydroxychloroquine/ 2020-04-13T14:41:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/gilead-reports-compassionate-use-data-of-remdesivir-in-covid-19/ 2020-04-13T14:33:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunomic-covid-19-vaccine/ 2020-04-13T14:05:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-nod-first-nf1-drug-koselugo/ 2020-04-13T11:57:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/eli-lilly-to-study-baricitinib-for-covid-19-treatment/ 2020-04-13T11:17:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/fujifilm-evaluates-avigan-to-treat-covid-19-in-us/ 2020-04-13T09:59:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vir-selects-samsung-biologics-to-produce-covid-19-antibodies/ 2020-04-13T09:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vir-samsung-biologics-covid-19-antibodies/ 2020-08-09T13:23:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/epidemiologist-daily-update-3/ 2020-04-11T07:24:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-from-the-analysts/ 2020-04-10T09:36:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-identifies-lead-coronavirus-drug-candidate/ 2020-04-10T10:43:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/epidemiologist-daily-update-2/ 2020-04-10T07:49:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ventilators-concern-covid-19/ 2020-04-14T21:38:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/pfizer-and-biontech-expand-their-covid-19-vaccine-partnership/ 2020-04-09T16:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/data-shows-majority-of-australian-sites-are-open-for-clinical-trial-activity/ 2024-03-05T17:13:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/job-market-slump-spreads-amid-growing-economic-gloom/ 2020-04-09T15:36:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/international-team-identify-six-potential-covid-19-drug-candidates/ 2020-04-09T13:34:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biomarkers-covid-19-trials/ 2022-07-11T08:53:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/up-to-two-months-post-peak-lockdown-needed-to-wipe-out-covid-19-according-to-globaldata/ 2020-04-09T13:00:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/tiziana-life-sciences-develops-covid-19-therapy-candidate/ 2020-04-09T12:22:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrakis-therapeutics-roche-deal/ 2020-04-09T12:06:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/covid-19-italy-us-uk/ 2020-04-09T08:32:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/queensland-uni-covid-vaccine-preclinical/ 2021-03-04T16:23:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/covid-19-healthcare-daily-update/ 2020-04-09T12:08:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/psychology-drug-regulators/ 2020-04-08T10:48:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-covid-19-antibodies-research/ 2020-04-09T09:35:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/why-uk-covid-19-deaths-are-being-undercounted-and-by-how-much/ 2020-04-09T09:05:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/coronavirus-company-news-summary-4/ 2020-04-09T10:08:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rheumatology-patients-covid-19/ 2022-07-11T08:53:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coronavirus-pandemic-preparedness-healthcare-services/ 2020-04-09T08:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/government-and-policy-update-from-the-new-statesman-3/ 2020-04-09T10:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/can-governments-escape-prolonged-recession/ 2020-04-09T10:22:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/epidemiologist-daily-update/ 2020-04-09T08:36:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/deals-analysis/mas/healthcare-sector-sees-growth-in-deal-activity-for-second-consecutive-week 2020-04-09T07:16:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oncoimmune-covid-19-therapy-trial/ 2022-07-11T08:54:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/coronavirus-pandemic-challenges-to-healthcare-professionals/ 2020-04-16T05:21:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/small-scale-milling-particle-size-distribution/ 2020-05-19T06:58:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/covid-19-poll-effective-vaccine-treatment-development/ 2020-04-08T18:30:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/112996/ 2020-04-09T07:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/vodafone-app-turns-your-phone-into-a-coronavirus-fighting-supercomputer/ 2020-04-09T07:55:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ipos-covid-19-impact/ 2021-11-25T10:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/stable-reductions-in-daily-covid-19-deaths-in-italy-and-spain-give-cause-for-hope/ 2020-04-08T14:22:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/us-covid-19-related-deaths-skew-world-percentage-trend/ 2020-04-08T14:25:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/uncategorized/cancer-research-uk-cuts-funding-amid-pandemic/ 2020-04-08T13:45:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-risdiplam-fda-postpones-decision/ 2020-04-08T13:33:49+00:00 daily 0.2